Antitumor mechanisms of molecules secreted by Trypanosoma cruzi in colon and breast cancer: A review

S Sadr, S Ghiassi, N Lotfalizadeh… - Anti-Cancer Agents …, 2023 - ingentaconnect.com
Background: Molecules secreted by Trypanosoma cruzi (T. cruzi) have beneficial effects on
the immune system and can fight against cancer by inhibiting the growth of tumor cells …

Comparative analysis of virulence mechanisms of trypanosomatids pathogenic to humans

AL de Castro Neto, JF Da Silveira… - Frontiers in Cellular and …, 2021 - frontiersin.org
Trypanosoma brucei, Leishmania spp., and T. cruzi are flagellate protozoans of the family
Trypanosomatidae and the causative agents of human African trypanosomiasis …

Desialylation in physiological and pathological processes: New target for diagnostic and therapeutic development

M Wei, PG Wang - Progress in Molecular Biology and Translational …, 2019 - Elsevier
Desialylation is a pivotal part of sialic acid metabolism, which initiates the catabolism of
glycans by removing the terminal sialic acid residues on glycans, thereby modulating the …

Pharmacological potential of new metronidazole/eugenol/dihydroeugenol hybrids against Trypanosoma cruzi in vitro and in vivo

E Gonçalves-Santos, IS Caldas, VÂ Fernandes… - International …, 2023 - Elsevier
Aims From well-delimited immunomodulatory, redox and antimicrobial properties;
metronidazole and eugenol were used as structural platforms to assembly two new …

Drugs and drug resistance in African and American trypanosomiasis

J Franco, L Scarone, MA Comini - Annual Reports in Medicinal Chemistry, 2018 - Elsevier
Diseases caused by several (sub) species of parasites from the genus Trypanosoma are a
major concern for public and animal health. Trypanosomes have a digenetic life cycle that …

Binding of triazole-linked galactosyl arylsulfonamides to galectin-3 affects Trypanosoma cruzi cell invasion

MF Marchiori, TB Riul, LO Bortot, P Andrade… - Bioorganic & Medicinal …, 2017 - Elsevier
The synthesis of the O-3 triazole-linked galactosyl arylsulfonamides 1–7 as potential
inhibitors of Trypanosoma cruzi cell invasion is described. These target compounds were …

B-1 Cells May Drive Macrophages Susceptibility to Trypanosoma cruzi Infection

RFDB Da Rocha, IF LaRocque-de-Freitas… - Frontiers in …, 2019 - frontiersin.org
B-1 cells can directly and indirectly influence the immune response. These cells are known
to be excellent producers of natural antibodies and can secrete a variety of …

The Recombinant Form of Trypanosoma cruzi P21 Controls Infection by Modulating Host Immune Response

FA Martins, MA Dos Santos, JG Santos… - Frontiers in …, 2020 - frontiersin.org
Trypanosoma cruzi P21 protein (P21) is a putative secreted and immunomodulatory
molecule with potent bioactive properties such as induction of phagocytosis and actin …

Human complement receptor type 1 (CR1) protein levels and genetic variants in chronic Chagas Disease

TL Sandri, KCF Lidani, FA Andrade, CG Meyer… - Scientific Reports, 2018 - nature.com
Complement is an essential element in both innate and acquired immunity contributing to
the immunopathogenesis of many disorders, including Chagas Disease (CD). Human …

The Screen of a Phage Display Library Identifies a Peptide That Binds to the Surface of Trypanosoma cruzi Trypomastigotes and Impairs Their Infection of Mammalian …

JI de Paula, EJ Lopes-Torres… - Frontiers in …, 2022 - frontiersin.org
Background Chagas is a neglected tropical disease caused by the protozoan parasite
Trypanosoma cruzi. On the order of seven million people are infected worldwide and current …